Related Experiment Video
Updated: Mar 15, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
p21(WAF1) Mediates Cell-Cycle Inhibition, Relevant to Cancer Suppression and Therapy
1Department of Hematology/Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, Pennsylvania. wafik.eldeiry@fccc.edu.
Abstract:
p21 (WAF1/CIP1; CDKN1a) is a universal cell-cycle inhibitor directly controlled by p53 and p53-independent pathways. Knowledge of the regulation and function of p21 in normal and cancer cells has opened up several areas of investigation and has led to novel therapeutic strategies. The discovery in 1993 and subsequent work on p21 has illuminated basic cellular growth control, stem cell phenotypes, the physiology of differentiation, as well as how cells respond to stress. There remain open questions in the signaling networks, the ultimate role of p21 in the p53-deficiency phenotype in the context of other p53 target defects, and therapeutic strategies continue to be a work in progress. Cancer Res; 76(18); 5189-91. ©2016 AACRSee related article by El-Deiry et al., Cancer Res 1994;54:1169-74Visit the Cancer Research 75(th) Anniversary timeline.
Insights
The cell-cycle inhibitor p21 (WAF1/CIP1; CDKN1a) plays a crucial role in cell growth, differentiation, and stress response. Further research is needed to fully understand its function in cancer and develop targeted therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p21 (WAF1/CIP1; CDKN1a) is a key cell-cycle inhibitor regulated by p53 and independent pathways.
- Its discovery has significantly advanced understanding of cellular growth, differentiation, and stress responses.
Observation:
- p21's role extends to basic cellular processes, including stem cell phenotypes.
- It is integral to how cells manage stress and maintain normal function.
Findings:
- Knowledge of p21 regulation and function has spurred novel therapeutic strategies for cancer.
- p21's involvement in p53-deficient cancers presents complex signaling network questions.
Implications:
- Continued investigation into p21 signaling networks is crucial for understanding cancer development.
- Therapeutic strategies targeting p21 are an ongoing area of development and refinement.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation

